Skip to main content
Journal cover image

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.

Publication ,  Journal Article
Kuo, TK; Hung, S-P; Chuang, C-H; Chen, C-T; Shih, Y-RV; Fang, S-CY; Yang, VW; Lee, OK
Published in: Gastroenterology
June 2008

BACKGROUND & AIMS: Liver transplantation is the primary treatment for various end-stage hepatic diseases but is hindered by the lack of donor organs and by complications associated with rejection and immunosuppression. There is increasing evidence to suggest the bone marrow is a transplantable source of hepatic progenitors. We previously reported that multipotent bone marrow-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells with almost 100% induction frequency under defined conditions, suggesting the potential for clinical applications. The aim of this study was to critically analyze the various parameters governing the success of bone marrow-derived mesenchymal stem cell-based therapy for treatment of liver diseases. METHODS: Lethal fulminant hepatic failure in nonobese diabetic severe combined immunodeficient mice was induced by carbon tetrachloride gavage. Mesenchymal stem cell-derived hepatocytes and mesenchymal stem cells were then intrasplenically or intravenously transplanted at different doses. RESULTS: Both mesenchymal stem cell-derived hepatocytes and mesenchymal stem cells, transplanted by either intrasplenic or intravenous route, engrafted recipient liver, differentiated into functional hepatocytes, and rescued liver failure. Intravenous transplantation was more effective in rescuing liver failure than intrasplenic transplantation. Moreover, mesenchymal stem cells were more resistant to reactive oxygen species in vitro, reduced oxidative stress in recipient mice, and accelerated repopulation of hepatocytes after liver damage, suggesting a possible role for paracrine effects. CONCLUSIONS: Bone marrow-derived mesenchymal stem cells can effectively rescue experimental liver failure and contribute to liver regeneration and offer a potentially alternative therapy to organ transplantation for treatment of liver diseases.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gastroenterology

DOI

EISSN

1528-0012

Publication Date

June 2008

Volume

134

Issue

7

Start / End Page

2111 / 2121.e3

Location

United States

Related Subject Headings

  • Time Factors
  • Reactive Oxygen Species
  • Oxidative Stress
  • Mice, SCID
  • Mice, Inbred NOD
  • Mice
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
  • Liver Regeneration
  • Liver Failure, Acute
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kuo, T. K., Hung, S.-P., Chuang, C.-H., Chen, C.-T., Shih, Y.-R., Fang, S.-C., … Lee, O. K. (2008). Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology, 134(7), 2111-2121.e3. https://doi.org/10.1053/j.gastro.2008.03.015
Kuo, Tom K., Shun-Pei Hung, Chiao-Hui Chuang, Chien-Tsun Chen, Yu-Ru V. Shih, Szu-Ching Y. Fang, Vincent W. Yang, and Oscar K. Lee. “Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.Gastroenterology 134, no. 7 (June 2008): 2111-2121.e3. https://doi.org/10.1053/j.gastro.2008.03.015.
Kuo TK, Hung S-P, Chuang C-H, Chen C-T, Shih Y-RV, Fang S-CY, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008 Jun;134(7):2111-2121.e3.
Kuo, Tom K., et al. “Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.Gastroenterology, vol. 134, no. 7, June 2008, pp. 2111-2121.e3. Pubmed, doi:10.1053/j.gastro.2008.03.015.
Kuo TK, Hung S-P, Chuang C-H, Chen C-T, Shih Y-RV, Fang S-CY, Yang VW, Lee OK. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008 Jun;134(7):2111-2121.e3.
Journal cover image

Published In

Gastroenterology

DOI

EISSN

1528-0012

Publication Date

June 2008

Volume

134

Issue

7

Start / End Page

2111 / 2121.e3

Location

United States

Related Subject Headings

  • Time Factors
  • Reactive Oxygen Species
  • Oxidative Stress
  • Mice, SCID
  • Mice, Inbred NOD
  • Mice
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
  • Liver Regeneration
  • Liver Failure, Acute